molecular profiling
Massive Bio, CureMatch Partner to Improve Oncology Clinical Trial, Precision Treatment Access
The partnership will combine CureMatch's decision support platform with Massive Bio's AI-based trial matching platform.
The company has validated its digital drug assignment algorithm in multiple preclinical, clinical, and real-world datasets and is eager to incorporate it into more research.
BostonGene, Little Warrior Foundation Partner to Develop Sarcoma-Specific Liquid Biopsy
Liquid biopsy tests will be designed to detect molecular alterations and fusions specific to sarcoma using cell-free DNA and RNA.
Synergy Oncology to Develop Tumor Profiling Test Using Sophia Genetics DDM Platform
Synergy will incorporate Sophia DDM to launch Totality, a tumor molecular profiling assay to help physicians match variants to therapies and clinical trials.
Caris Life Sciences, ConcertAI Partner on Molecular Oncology R&D Platform
Caris and ConcertAI will combine their multiomic and multimodal databases and AI technology to create a unified platform for use in oncology and hematology.
Apr 6, 2022
BostonGene Closes $150M Series B Funding Round
Feb 25, 2021
Natera Revenues Grow 35 Percent in Q4
Jul 30, 2019